Journavx 50 MG Oral Tablet

RxCUI: 2704839
RxNorm name: Journavx 50 MG Oral Tablet
Display name: Journavx 50 MG Oral Tablet
Full name: Journavx 50 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JOURNAVX	SUZETRIGINE	Sportpharm LLC	d229cf71-96ec-4206-960b-d56fafc250ac	2026-07-21	Warnings, Adverse reactions	Exact identifier rxcui: 2704839
JOURNAVX	SUZETRIGINE	Vertex Pharmaceuticals Incorporated	f0976da4-1d20-4517-945c-b60ed2f41c12	2026-04-13	Warnings, Adverse reactions	Exact identifier rxcui: 2704839

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f0976da4-1d20-4517-945c-b60ed2f41c12	JOURNAVX 50 MG Oral Tablet [PSN] · suzetrigine 50 MG Oral Tablet [Journavx] [SBD] · Journavx 50 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use JOURNAVX safely and effectively. See full prescribing information for JOURNAVX. JOURNAVX (suzetrigine) tablets, for oral use Initial U.S. Approval: 2025	20260413